Birmingham Biotech Nominated as a Finalist for Two Med-Tech Innovation Awards

Birmingham Biotech is delighted to announce that it has been voted as a finalist for two award categories in the Med-Tech Innovation Awards 2022.

The BHM® Anti-Viral Nasal Spray, an easy-to-use nasal device which is designed to help prevent the inhalation of infectious viruses such as SARS-CoV-2, has been nominated as a finalist for the Materials Innovation Award.

The BHM® COVID-19 Sealing Tube Test, a sustainable COVID-19 lateral flow test that uses 75% less plastic compared to traditional test kits, has been voted as a finalist for the Sustainability Award.

We’re proud to be developing healthcare solutions that benefit both people and the planet, and we’re looking forward to celebrating the incredible talent in the life sciences and healthcare technology sector at the awards ceremony on 8th June!  

Find out more about the awards here: https://www.med-techawards.com/awards/en/page/finalists